Validation through in vitro experiments confirmed that KLF5 is upregulated in glioblastoma (GBM) and bladder cancer, and that its knockdown effectively suppresses GBM and bladder cancer growth. The gene discussed is KLF5; the disease is urinary bladder carcinoma.